Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Inventory Average (2014 - 2026)

Vericel (VCEL) posted Inventory Average of $18.4 million for Q2 2026, up 2.29% sequentially from $18.0 million in Q1 2026, and up 8.24% YoY from $17.0 million in Q2 2025.

Analysis

Vericel (VCEL) Inventory Average (2014 - 2026) Analysis & Trends

Vericel has reported Inventory Average for 13 years, with the latest figure at $18.4 million in Q2 2026.

  • Quarterly Inventory Average rose 8.24% year-over-year to $18.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.4 million (up 8.24% YoY) and the FY2025 annual result came in at $17.5 million, up 14.68% from the prior year.
  • Inventory Average improved to $18.4 million in Q2 2026 per VCEL's latest filing, from $18.0 million in the prior quarter.
  • Over five years, Inventory Average peaked at $18.4 million in Q2 2026 and troughed at $12.9 million in Q4 2023.
  • A 5-year average of $15.7 million and a median of $16.0 million in 2022 frame the typical range for Inventory Average.
  • The sharpest annual moves came in 2022 and 2023: Inventory Average surged 41.1% in 2022, then declined 21.42% in 2023.
  • Over 5 years, Inventory Average stood at $16.4 million in 2022, then decreased by 21.42% to $12.9 million in 2023, then advanced by 28.87% to $16.6 million in 2024, then climbed by 7.81% to $17.9 million in 2025, then rose by 2.85% to $18.4 million in 2026.
  • According to Business Quant data, Inventory Average over the past three periods registered $18.4 million, $18.0 million, and $17.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.77 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 3.09 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 213.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 707.10 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 90.57 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 137.65 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 18.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.37 Mn
Mar 31, 2026 17.96 Mn
Dec 31, 2025 17.86 Mn
Sep 30, 2025 17.49 Mn
Jun 30, 2025 16.97 Mn
Mar 31, 2025 17.24 Mn
Dec 31, 2024 16.56 Mn
Sep 30, 2024 15.32 Mn
Jun 30, 2024 14.22 Mn
Mar 31, 2024 13.32 Mn
Dec 31, 2023 12.85 Mn
Sep 30, 2023 13.25 Mn
Jun 30, 2023 14.63 Mn
Mar 31, 2023 15.68 Mn
Dec 31, 2022 16.36 Mn
Sep 30, 2022 16.33 Mn
Jun 30, 2022 15.16 Mn
Mar 31, 2022 13.88 Mn
Dec 31, 2021 13.22 Mn
Sep 30, 2021 13.01 Mn